Disclosure Intervention for People in Treatment for Opioid Use Disorder
ConditionOpioid Use Disorder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Delaware
About this trial
The goal of this clinical trial is to test a disclosure intervention among people in treatment for opioid use disorder. The main question it aims to answer is whether people who receive a disclosure intervention have better treatment- and recovery-related outcomes one year after receiving the intervention. Participants will complete a brief disclosure intervention designed to help them (1) make key disclosures related to disclosure and (2) build skills to disclose. Researchers will compare results to participants in a waitlist comparator condition, who receive the intervention at the end of the study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Client of Brandywine Counseling & Community Services
Receiving opioid use disorder treatment at Brandywine Counseling & Community Services
Considering disclosing one's opioid use disorder history and/or treatment to someone new
Disqualifiers
Diagnosis of schizophrenia
Participation in pilot study of intervention
Trial design
Design model
Parallel
Treatments tested in this trial
Disclosing Recovery: A Decision Aid and Toolkit
BehavioralThe Disclosing Recovery intervention is designed to help people in treatment for opioid use disorder (1) make key decisions regarding disclosure, including whether, why, what, how, and when to disclose, and (2) build skills to disclose, including planning what to say, practicing disclosure, and preparing for negative responses.
Treatment groups
480 Participants
are divided into 2 treatment groupsGroup A: Disclosing RecoveryExperimental treatment 1 intervention
Group B: Waitlist ComparatorNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Retention in treatment
Whether participants are retained in treatment 1 year after baseline
Time frame
1 year2
Illicit opioid use
Percentages of drug screens that are positive for illicit opioid use
Time frame
1 yearSecondary outcomes
1
Recovery capital score
Average scores on recovery capital measure (titled: Brief Assessment of Recovery Capital); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher values indicate greater recovery capital.
Time frame
1 year2
Quality of life score
Average scores on quality of life measure (titled: European Health Interview Survey-Quality of Life - 8 item); items are measured on a 1-5 point Likert-type scale, and composite scores range from 1-5. Higher scores indicate greater quality of life.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Delaware
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Brandywine Counseling and Community Services
Collaborator
Source ClinicalTrials.gov